In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Actavis signs preliminary deal to sell Western European businesses to Aurobindo; finalized

Executive Summary

The European division of Indian generic drug and API manufacturer Aurobindo Pharma Ltd. signed a preliminary agreement to acquire Actavis PLC’s businesses in seven Western European countries: France, Italy, Spain, Portugal, Belgium, Germany, and the Netherlands. The sale is contingent upon antitrust approvals and completion of employee consultation processes. Depending on Aurobindo’s cash and net working capital at the time the transaction is finalized, the purchase price could be €30mm ($41mm).
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies